An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond.

Ruba S SaadehPaola A RamosAlicia Algeciras-SchimnichEoin P FlanaganSean J Pittock Maria Alice Vieira Willrich

Published in: Clinical chemistry (2022)

Laboratory testing for demyelinating disorders using CSF and serum are routine practices that can benefit from an update, as novel biomarker-defined entities have reduced the potential for MS misdiagnosis, and CSF/serum biomarkers reinstated in the diagnostic criteria of MS.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
white matter
healthcare
primary care
clinical practice
cerebrospinal fluid
human health